twoXAR is a software-driven drug discovery company. They leverage their computational platform to identify promising drug candidates, validate & de-risk them through preclinical studies, and progress candidates to the clinic through industry and investor partnerships. twoXAR is financially backed by Andreessen Horowitz and the Stanford-StartX Fund and engaged in collaborations with leading academic research and biopharma R&D organizations.
Biological Data Extraction: Sourcing, normalizing, and identifying disease signals in biological data sets.
Automated Model Generation: Automatically generating a mathematical drug-disease model.
Feature Identification: Extracting relevant factors from the model to guide drug classification.
Candidate Analysis: Candidate analysis and classifying the efficacy of each drug using machine learning.